By Ron Elli, Ph.D.|2023-08-28T05:47:03+00:00July 24th, 2023|Categories: News & Trends|Tags: Amgen, big pharma, celebrity weight loss, Chelsea Handler, Compounded Semaglutide, Eli Lilly, Endocrinology, FDA, GIP, GLP-1, glp1, glucagon, Glucagon-like peptide-1, glycemic control, medicated weight loss, novo, NovoNordisk, Orforglipron, Ozempic, Ozempic butt, Retatrutide, Rybelsus, Saxenda, Semaglutide, shot, thyroid cancer, Trulicity, type 2 diabetes, Victoza, Wegovy, weight loss injection, weight loss injection shots|0 Comments
The Western world's obsession with finding a magic cure for fatness has come down to a diabetic medicine shot called [...]
By MBC Contributor|2023-08-14T01:24:31+00:00March 7th, 2023|Categories: News & Trends|Tags: Amgen, big pharma, celebrity weight loss, Chelsea Handler, Compounded Semaglutide, Eli Lilly, FDA, GIP, GLP-1, glp1, glucagon, glycemic control, medicated weight loss, novo, NovoNordisk, Orforglipron, Ozempic, Retatrutide, Rybelsus, Saxenda, Semaglutide, shot, thyroid cancer, Trulicity, type 2 diabetes, Victoza, Wegovy, weight loss injection, weight loss injection shots|6 Comments
Weight loss can be a daunting task, and sometimes we need a little extra help. With over 650 million obese [...]
